GreenMark Biomedical

GreenMark Biomedical

Minimally invasive healthcare company.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor investor investor

€0.0

round
investor

€0.0

round
investor investor investor investor

€0.0

round
N/A

€0.0

round
*

$200k

Grant
Total Funding000k
Notes (0)
More about GreenMark Biomedical
Made with AI
Edit

GreenMark Biomedical Inc. operates as a minimally invasive healthcare company, positioning itself at the intersection of biotechnology and dental care. Founded in Michigan in 2016 by Dr. Steven Bloembergen, the firm's mission is to enable oral healthcare professionals to preserve teeth through early diagnosis and less invasive treatment options. Dr. Bloembergen, who serves as Chairman and CEO, brings over three decades of experience in biomaterials development and commercialization. His journey includes founding EcoSynthetix in 1996, a company that became a global manufacturer of bio-based nanoparticles and where the foundational technology for GreenMark was developed through a network of university collaborations. This prior venture culminated in a successful IPO on the Toronto Stock Exchange in 2011.

The company's core technology, developed in partnership with the University of Michigan, revolves around bioresorbable starch nanoparticles. These food-grade particles act as carriers for dental applications and are naturally degraded by enzymes in saliva. GreenMark's business model focuses on developing and commercializing a suite of products for dental professionals that address the prevalent issue of dental caries, or tooth decay. The company generates revenue through the sale of these products to dental clinics and professionals.

A key product is the LumiCare™ Caries Detection Rinse, which received FDA 510(k) clearance as a Class II Medical Device in April 2021. This prescription-use rinse contains fluorescently labeled starch particles that penetrate the porous subsurface of early-stage carious lesions. When a standard dental curing light is used, these particles illuminate the affected areas, enhancing visualization of pre-cavities that might otherwise be undetectable. The particles are designed to be bio-resorbed by the time a patient's appointment is over. Another product, CrystLCare™ Biorestorative, is a fluoride-free dental strip for treating sensitivity. It uses the same nanoparticle technology to deliver minerals like calcium and phosphate to block exposed dentinal tubules, providing long-lasting relief.

Keywords: dental diagnostics, caries detection, minimally invasive dentistry, nanoparticle technology, biomaterials, oral healthcare, tooth decay prevention, LumiCare Caries Detection Rinse, biorestorative materials, dental sensitivity treatment, preventive dental care, Steven Bloembergen, University of Michigan, starch nanoparticles, FDA clearance, Class II Medical Device, CrystLCare, enamel remineralization, dental technology, oral health management

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo